CN Stock MarketDetailed Quotes

605507 Guobang Pharma Ltd.

Watchlist
  • 17.53
  • +0.28+1.62%
Not Open Aug 12 15:00 CST
9.80BMarket Cap15.89P/E (TTM)

Guobang Pharma Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-5.07%1.34B
-6.49%5.35B
-1.46%4.05B
3.93%2.81B
19.90%1.41B
26.98%5.72B
28.01%4.11B
20.56%2.7B
2.96%1.18B
7.11%4.51B
Operating revenue
-5.07%1.34B
-6.49%5.35B
-1.46%4.05B
3.93%2.81B
19.90%1.41B
26.98%5.72B
28.01%4.11B
20.56%2.7B
2.96%1.18B
7.11%4.51B
Other operating revenue
----
28.96%22.35M
----
-6.10%7.45M
----
39.43%17.33M
----
114.71%7.94M
----
75.70%12.43M
Total operating cost
-6.76%1.1B
-0.21%4.65B
5.92%3.48B
11.64%2.38B
27.03%1.18B
27.27%4.66B
26.07%3.28B
18.00%2.13B
1.35%928.81M
12.11%3.67B
Operating cost
-6.13%971.46M
-1.15%4.1B
3.67%3.05B
11.26%2.12B
27.67%1.03B
31.68%4.14B
32.76%2.95B
22.58%1.9B
1.14%810.64M
13.39%3.15B
Operating tax surcharges
-13.15%6.98M
9.37%36.19M
3.31%23.12M
28.54%16.49M
42.24%8.03M
31.99%33.09M
21.99%22.38M
8.87%12.83M
-10.87%5.65M
2.17%25.07M
Operating expense
12.29%17.23M
15.66%74.2M
37.55%53.85M
26.43%32.49M
3.72%15.34M
14.84%64.15M
-29.04%39.15M
-23.55%25.7M
0.15%14.79M
2.55%55.86M
Administration expense
-0.76%75.75M
3.40%303.08M
9.69%229.55M
19.59%152.45M
16.97%76.32M
15.62%293.11M
12.71%209.28M
9.40%127.48M
17.06%65.25M
29.58%253.51M
Financial expense
-469.45%-8.97M
31.95%-46.28M
33.54%-44.9M
-46.50%-40.51M
-289.42%-1.57M
-342.43%-68.01M
-424.60%-67.55M
-234.76%-27.65M
-83.89%831.31K
-65.71%28.05M
-Interest expense (Financial expense)
40.97%7.42M
36.46%22.58M
40.00%18.2M
105.55%9.49M
148.91%5.27M
-42.38%16.55M
-43.29%13M
-74.01%4.61M
-76.77%2.12M
-19.14%28.72M
-Interest Income (Financial expense)
34.73%-10.77M
-76.34%-51.78M
-138.81%-41.48M
-309.92%-29.87M
-444.03%-16.5M
-59.76%-29.36M
-75.00%-17.37M
-39.56%-7.29M
-18.45%-3.03M
-34.95%-18.38M
Research and development
-19.64%37.65M
-3.56%190.51M
20.51%162.76M
12.51%97.44M
48.02%46.86M
27.22%197.54M
27.16%135.06M
26.55%86.61M
-3.97%31.66M
13.18%155.27M
Credit Impairment Loss
-72.58%-4.49M
137.76%4.72M
-283.71%-19.81M
33.58%-4.72M
68.89%-2.6M
-1,258.59%-12.5M
-4,282.00%-5.16M
-54.07%-7.11M
-80.87%-8.37M
-269.26%-920.21K
Asset Impairment Loss
-764.96%-8.83M
-13.50%-31.45M
87.26%-1.25M
-114.23%-17.02M
87.08%-1.02M
46.54%-27.71M
53.28%-9.79M
-2,995.78%-7.94M
-93.61%-7.9M
-259.83%-51.83M
Other net revenue
-1,030.25%-2.5M
332.98%7.64M
-197.41%-10.95M
-606.56%-16.37M
103.49%268.79K
89.49%-3.28M
202.61%11.24M
286.62%3.23M
-67.42%-7.7M
-4,498.87%-31.19M
Fair value change income
---380.32K
126.89%10.34M
----
--3.64M
----
-27.15%4.56M
----
----
----
17,889.16%6.26M
Invest income
214.11%7.27M
-32.33%13.22M
-75.50%4.67M
-111.51%-1.44M
-61.50%2.31M
356.92%19.54M
1,832.38%19.07M
3,101.68%12.55M
1,449.49%6.01M
30.72%4.28M
-Including: Investment income associates
-70.06%-695.27K
108.12%60.46K
-75.65%-1.53M
63.42%-287.31K
18.70%-408.83K
52.29%-744.63K
-46.54%-871.48K
-32.07%-785.45K
-162.65%-502.9K
-17.69%-1.56M
Asset deal income
----
----
----
----
----
-99.99%44.63
----
----
----
119.83%301.93K
Other revenue
149.33%3.94M
-15.87%10.8M
-23.60%5.44M
-44.48%3.18M
-38.35%1.58M
19.62%12.84M
-17.96%7.12M
0.92%5.73M
-45.90%2.56M
-5.87%10.73M
Operating profit
2.41%236.11M
-33.30%702.26M
-32.89%563.98M
-27.84%417.52M
-3.77%230.55M
30.18%1.05B
40.74%840.33M
31.57%578.62M
8.30%239.59M
-13.60%808.77M
Add:Non operating Income
113.16%482.07K
489.23%3.32M
127.98%2.12M
-35.51%377.86K
-30.73%226.15K
-94.18%562.61K
-90.75%928.6K
-63.46%585.88K
-69.77%326.47K
-48.37%9.67M
Less:Non operating expense
19.60%2.56M
-55.45%7.93M
-39.56%6.54M
-54.94%4.99M
-55.44%2.14M
52.67%17.8M
79.46%10.82M
154.53%11.07M
159.76%4.81M
2.24%11.66M
Total profit
2.36%234.02M
-32.64%697.65M
-32.62%559.55M
-27.32%412.91M
-2.75%228.63M
28.37%1.04B
38.16%830.44M
30.00%568.14M
6.64%235.1M
-14.48%806.78M
Less:Income tax cost
5.30%35.44M
-23.78%87.67M
-34.09%71.89M
-23.37%56.05M
-3.26%33.66M
14.39%115.02M
37.32%109.08M
23.98%73.14M
-0.87%34.8M
-24.48%100.55M
Net profit
1.85%198.58M
-33.74%609.98M
-32.40%487.66M
-27.91%356.86M
-2.66%194.97M
30.36%920.62M
38.28%721.36M
30.94%495M
8.06%200.31M
-12.84%706.23M
Net profit from continuing operation
1.85%198.58M
-33.74%609.98M
-32.40%487.66M
-27.91%356.86M
-2.66%194.97M
30.36%920.62M
38.28%721.36M
30.94%495M
8.06%200.31M
-12.84%706.23M
Less:Minority Profit
-144.57%-152.44K
-780.84%-2.49M
-586.07%-1.42M
-1,318.46%-614.41K
488.30%342.02K
-241.63%-282.17K
-48.41%291.63K
-112.69%-43.32K
-134.02%-88.08K
-30.90%199.23K
Net profit of parent company owners
2.11%198.73M
-33.49%612.46M
-32.17%489.07M
-27.79%357.47M
-2.88%194.63M
30.43%920.9M
38.38%721.06M
31.07%495.04M
8.26%200.39M
-12.84%706.03M
Earning per share
Basic earning per share
2.86%0.36
-33.33%1.1
-31.78%0.88
-28.09%0.64
-2.78%0.35
19.57%1.65
21.70%1.29
11.25%0.89
-7.69%0.36
-19.30%1.38
Diluted earning per share
2.86%0.36
-33.33%1.1
-31.78%0.88
-28.09%0.64
-2.78%0.35
19.57%1.65
21.70%1.29
11.25%0.89
-7.69%0.36
-19.30%1.38
Other composite income
Total composite income
1.85%198.58M
-33.74%609.98M
-32.40%487.66M
-27.91%356.86M
-2.66%194.97M
30.36%920.62M
38.28%721.36M
30.94%495M
8.06%200.31M
-12.84%706.23M
Total composite income of parent company owners
2.11%198.73M
-33.49%612.46M
-32.17%489.07M
-27.79%357.47M
-2.88%194.63M
30.43%920.9M
38.38%721.06M
31.07%495.04M
8.26%200.39M
-12.84%706.03M
Total composite income of minority owners
-144.57%-152.44K
-780.84%-2.49M
-586.07%-1.42M
-1,318.46%-614.41K
488.30%342.02K
-241.63%-282.17K
-48.41%291.63K
-112.69%-43.32K
-134.02%-88.08K
-30.90%199.23K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -5.07%1.34B-6.49%5.35B-1.46%4.05B3.93%2.81B19.90%1.41B26.98%5.72B28.01%4.11B20.56%2.7B2.96%1.18B7.11%4.51B
Operating revenue -5.07%1.34B-6.49%5.35B-1.46%4.05B3.93%2.81B19.90%1.41B26.98%5.72B28.01%4.11B20.56%2.7B2.96%1.18B7.11%4.51B
Other operating revenue ----28.96%22.35M-----6.10%7.45M----39.43%17.33M----114.71%7.94M----75.70%12.43M
Total operating cost -6.76%1.1B-0.21%4.65B5.92%3.48B11.64%2.38B27.03%1.18B27.27%4.66B26.07%3.28B18.00%2.13B1.35%928.81M12.11%3.67B
Operating cost -6.13%971.46M-1.15%4.1B3.67%3.05B11.26%2.12B27.67%1.03B31.68%4.14B32.76%2.95B22.58%1.9B1.14%810.64M13.39%3.15B
Operating tax surcharges -13.15%6.98M9.37%36.19M3.31%23.12M28.54%16.49M42.24%8.03M31.99%33.09M21.99%22.38M8.87%12.83M-10.87%5.65M2.17%25.07M
Operating expense 12.29%17.23M15.66%74.2M37.55%53.85M26.43%32.49M3.72%15.34M14.84%64.15M-29.04%39.15M-23.55%25.7M0.15%14.79M2.55%55.86M
Administration expense -0.76%75.75M3.40%303.08M9.69%229.55M19.59%152.45M16.97%76.32M15.62%293.11M12.71%209.28M9.40%127.48M17.06%65.25M29.58%253.51M
Financial expense -469.45%-8.97M31.95%-46.28M33.54%-44.9M-46.50%-40.51M-289.42%-1.57M-342.43%-68.01M-424.60%-67.55M-234.76%-27.65M-83.89%831.31K-65.71%28.05M
-Interest expense (Financial expense) 40.97%7.42M36.46%22.58M40.00%18.2M105.55%9.49M148.91%5.27M-42.38%16.55M-43.29%13M-74.01%4.61M-76.77%2.12M-19.14%28.72M
-Interest Income (Financial expense) 34.73%-10.77M-76.34%-51.78M-138.81%-41.48M-309.92%-29.87M-444.03%-16.5M-59.76%-29.36M-75.00%-17.37M-39.56%-7.29M-18.45%-3.03M-34.95%-18.38M
Research and development -19.64%37.65M-3.56%190.51M20.51%162.76M12.51%97.44M48.02%46.86M27.22%197.54M27.16%135.06M26.55%86.61M-3.97%31.66M13.18%155.27M
Credit Impairment Loss -72.58%-4.49M137.76%4.72M-283.71%-19.81M33.58%-4.72M68.89%-2.6M-1,258.59%-12.5M-4,282.00%-5.16M-54.07%-7.11M-80.87%-8.37M-269.26%-920.21K
Asset Impairment Loss -764.96%-8.83M-13.50%-31.45M87.26%-1.25M-114.23%-17.02M87.08%-1.02M46.54%-27.71M53.28%-9.79M-2,995.78%-7.94M-93.61%-7.9M-259.83%-51.83M
Other net revenue -1,030.25%-2.5M332.98%7.64M-197.41%-10.95M-606.56%-16.37M103.49%268.79K89.49%-3.28M202.61%11.24M286.62%3.23M-67.42%-7.7M-4,498.87%-31.19M
Fair value change income ---380.32K126.89%10.34M------3.64M-----27.15%4.56M------------17,889.16%6.26M
Invest income 214.11%7.27M-32.33%13.22M-75.50%4.67M-111.51%-1.44M-61.50%2.31M356.92%19.54M1,832.38%19.07M3,101.68%12.55M1,449.49%6.01M30.72%4.28M
-Including: Investment income associates -70.06%-695.27K108.12%60.46K-75.65%-1.53M63.42%-287.31K18.70%-408.83K52.29%-744.63K-46.54%-871.48K-32.07%-785.45K-162.65%-502.9K-17.69%-1.56M
Asset deal income ---------------------99.99%44.63------------119.83%301.93K
Other revenue 149.33%3.94M-15.87%10.8M-23.60%5.44M-44.48%3.18M-38.35%1.58M19.62%12.84M-17.96%7.12M0.92%5.73M-45.90%2.56M-5.87%10.73M
Operating profit 2.41%236.11M-33.30%702.26M-32.89%563.98M-27.84%417.52M-3.77%230.55M30.18%1.05B40.74%840.33M31.57%578.62M8.30%239.59M-13.60%808.77M
Add:Non operating Income 113.16%482.07K489.23%3.32M127.98%2.12M-35.51%377.86K-30.73%226.15K-94.18%562.61K-90.75%928.6K-63.46%585.88K-69.77%326.47K-48.37%9.67M
Less:Non operating expense 19.60%2.56M-55.45%7.93M-39.56%6.54M-54.94%4.99M-55.44%2.14M52.67%17.8M79.46%10.82M154.53%11.07M159.76%4.81M2.24%11.66M
Total profit 2.36%234.02M-32.64%697.65M-32.62%559.55M-27.32%412.91M-2.75%228.63M28.37%1.04B38.16%830.44M30.00%568.14M6.64%235.1M-14.48%806.78M
Less:Income tax cost 5.30%35.44M-23.78%87.67M-34.09%71.89M-23.37%56.05M-3.26%33.66M14.39%115.02M37.32%109.08M23.98%73.14M-0.87%34.8M-24.48%100.55M
Net profit 1.85%198.58M-33.74%609.98M-32.40%487.66M-27.91%356.86M-2.66%194.97M30.36%920.62M38.28%721.36M30.94%495M8.06%200.31M-12.84%706.23M
Net profit from continuing operation 1.85%198.58M-33.74%609.98M-32.40%487.66M-27.91%356.86M-2.66%194.97M30.36%920.62M38.28%721.36M30.94%495M8.06%200.31M-12.84%706.23M
Less:Minority Profit -144.57%-152.44K-780.84%-2.49M-586.07%-1.42M-1,318.46%-614.41K488.30%342.02K-241.63%-282.17K-48.41%291.63K-112.69%-43.32K-134.02%-88.08K-30.90%199.23K
Net profit of parent company owners 2.11%198.73M-33.49%612.46M-32.17%489.07M-27.79%357.47M-2.88%194.63M30.43%920.9M38.38%721.06M31.07%495.04M8.26%200.39M-12.84%706.03M
Earning per share
Basic earning per share 2.86%0.36-33.33%1.1-31.78%0.88-28.09%0.64-2.78%0.3519.57%1.6521.70%1.2911.25%0.89-7.69%0.36-19.30%1.38
Diluted earning per share 2.86%0.36-33.33%1.1-31.78%0.88-28.09%0.64-2.78%0.3519.57%1.6521.70%1.2911.25%0.89-7.69%0.36-19.30%1.38
Other composite income
Total composite income 1.85%198.58M-33.74%609.98M-32.40%487.66M-27.91%356.86M-2.66%194.97M30.36%920.62M38.28%721.36M30.94%495M8.06%200.31M-12.84%706.23M
Total composite income of parent company owners 2.11%198.73M-33.49%612.46M-32.17%489.07M-27.79%357.47M-2.88%194.63M30.43%920.9M38.38%721.06M31.07%495.04M8.26%200.39M-12.84%706.03M
Total composite income of minority owners -144.57%-152.44K-780.84%-2.49M-586.07%-1.42M-1,318.46%-614.41K488.30%342.02K-241.63%-282.17K-48.41%291.63K-112.69%-43.32K-134.02%-88.08K-30.90%199.23K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg